Oslo ,6 September 2021 : Option holders underNEXT Biometrics Group ASA's (the "Company", OSE ticker: NEXT) share option programs have today exercised a total of 167,877 options as set out below and as per the terms and conditions of the share option programs. The exercised options will be settled by issuance of new shares in the Company. o In total 48,500 options were exercised atNOK 2.49 per option. o In total 91,670 options were exercised atNOK 5.97 per option. o In total 27,707 options were exercised atNOK 6.52 per option. Further to the above, the board of directors of the Company has in a board meeting held today, on6 September 2021 , resolved to increase the Company's share capital withNOK 167,877 by the issuance of 167,877 new shares, each with a nominal value ofNOK 1.00 . The share issue was resolved pursuant to an authorization to increase the Company's share capital granted by the annual general meeting of shareholders on12 May 2021 , and for the purpose of facilitating settlement of the exercised options. The exercise period for the options commenced on31 August 2021 at 10:00 hours (CEST) and ended on today, on6 September 2021 , at 10:00 hours (CEST). All of the exercised options have been granted under the Company's share option program, as described in the Company's latest annual financial statements and report, which is based on guidelines approved by the general meeting of shareholders. Following the registration of the share capital increase with theNorwegian Register ofBusiness Enterprises (Nw. Foretaksregisteret), the new share capital of the Company will beNOK 91,680,763 , divided into 91,680,763 shares, each with a nominal value ofNOK 1.00 . The share capital increase will be registered with theNorwegian Register ofBusiness Enterprises as soon as practically possible after the share contribution has been paid in full. This information is subject to the disclosure requirements pursuant to Article 19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act. NEXT Investor contact:Peter Heuman (CEO), peter.heuman@nextbiometrics.comEirik Underthun (CFO), eirik.underthun@nextbiometrics.com
Click here for more information
© Oslo Bors ASA, source